Plasma concentration of selected neuropeptides in patients suffering from psoriasis

Experimental Dermatology

Volumn 16, Issue 5, 2007, Pages 421-428

  Reich, Adam ^a   Orda, Alina ^a   Wiśnicka, Beata ^a   Szepietowski, Jacek C ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Calcitonin gene related peptide; Neuropeptide Y; Neuropeptides; Psoriasis; Substance P; Vasoactive intestinal peptide

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; DITHRANOL; KERATOLYTIC AGENT; METHOXSALEN; NEUROPEPTIDE; NEUROPEPTIDE Y; SUBSTANCE P; TAR;

ADULT; AGED; ANAMNESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PSORIASIS; PSORIASIS SEVERITY INDEX; PUVA; RADIOIMMUNOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUROPEPTIDE Y; NEUROPEPTIDES; PSORIASIS; STRESS; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 34247121974     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00544.x     Document Type: Article

References (51)

1. Peters BP, Weissman FG, Gill MA. Pathophysiology and treatment of psoriasis. Am J Health-Syst Pharm 2000: 57: 645-659.
2. Bos JD, De Rie MA. The pathogenesis of psoriasis: Immunological facts and speculations. Immunol Today 1999: 20: 40-46.
3. Sano S, Chan KS, Carbajal S et al. STAT3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005: 11: 43-49.
4. Reich A, Szepietowski JC, Wiśnicka B, Pacan P. Does stress influence itching in psoriatic patients? Dermatol Psychosom 2003: 4: 151-155.
5. Ergun T, Eksioglu-Demiralp E, Direskeneli H, Mumcu G, Gurbuz O. TCRγδ (+) T-cell response to streptococcal antigens in patients with psoriasis. Arch Dermatol Res 2005: 296: 536-538.
6. O'Kane M, Murphy EP, Kirby B. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol 2006: 15: 143-153.
7. Arnetz BB, Fjellner B, Eneroth P, Kallner A. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985: 47: 528-541.
8. Raychaudhuri SP, Farber EM. Neuroimmunologic aspects of psoriasis. Cutis 2000: 66: 357-362.
9. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997: 137: 843-850.
10. Peters EM, Kuhlmei A, Tobin DJ, Muller-Rover S, Klapp BF, Arck PC. Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 2005: 19: 252-262.
11. Scholzen TE, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune system. Exp Dermatol 1998: 7: 81-96.
12. Raychaudhuri SP, Farber EM. Are sensory nerves essential for the development of psoriasis lesions? J Am Acad Dermatol 1993: 28: 488-489.
13. Harvima IT, Viinamäki H, Naukkarinen A et al. Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. Psychother Psychosom 1993: 60: 168-176.
14. Naukkarinen A, Harvima I, Paukonnen K, Aalto ML, Horsmanheimo M. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 1993: 285: 341-346.
15. Chan J, Smoller BR, Raychauduri SP, Jiang WY, Farber EM. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 1997: 289: 611-616.
16. Jiang WY, Raychaudhuri SP, Farber EM. Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. Int J Dermatol 1998: 37: 572-574.
17. Eedy DJ, Johnston CF, Shaw C, Buchanan KD. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol 1991: 96: 434-438.
18. Staniek V, Doutremepuich J-D, Schmitt D, Claudy A, Misery L. Expression of substance P receptors in normal and psoriatic skin. Pathobiology 1999: 67: 51-54.
19. Pincelli C, Fantini F, Giardinbo L et al. Autoradiographic detection of substance P receptors in normal and psoriatic skin. J Invest Dermatol 1993: 101: 301-304.
20. Anand P, Springall DR, Blank MA, Sellu D, Polak JM, Bloom SR. Neuropeptides in skin diseases: Increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 1991: 124: 547-549.
21. Pincelli C, Fantini F, Romualdi P et al. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 1992: 98: 421-427.
22. He Y, Ding G, Wang X, Zhu T, Fan S. Calcitonin gene-related peptide in Langerhans cells in psoriatic plaque lesions. Chin Med J 2000: 113: 747-751.
23. Delfino M, Fabbrocini G, Brunetti B, Procaccini EM, Santoianni P. Peptide T in the treatment of severe psoriasis. Acta Derm Venereol (Stockh) 1992: 72: 68-69.
24. Talme T, Rozell BL, Sundqvist KG, Wetterberg L, Marcusson JA. Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment. Arch Dermatol Res 1995: 287: 553-557.
25. Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk HH Jr. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 1986: 15: 504-507.
26. Ellis CN, Berberian B, Sulica VI et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993: 29: 438-442.
27. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol 1994: 46: 517-522.
28. Mozzanica N, Cattaneo A, Vignati G, Finzi A. Plasma neuropeptide levels in psoriasis. Acta Derm Venerol Suppl (Stockh) 1994: 186: 67-68.
29. Walls AF, Brain SD, Desai A et al. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem Pharmacol 1992: 43: 1243-1248.
30. Santavirta N, Konttinen YT, Törnwall J et al. Neuropeptides of the autonomic nervous system in Sjögren's syndrome. Ann Rheum Dis 1997: 56: 737-740.
31. Rydning A, Lyng O, Aase S, Gronbech JE. Substance P attenuate gastric hyperemia by mast cell-dependent mechanism in the damaged gastric mucosa. Am J Physiol 1999: 277: G1064-G1073.
32. Teresiak E, Czarnecka-Operacz M. Neurogenic skin inflammation - an updated knowledge. Post Dermatol Alergol 2005: 22: 38-45.
33. Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: Comparative evaluation of itch-associated cutaneous factors. Br J Dermatol 2003: 149: 718-730.
34. Huskic J, Alendar F, Matavulj A, Ostoic L. Serum angiotensin converting enzyme in patients with psoriasis. Med Arch 2004: 58: 202-205.
35. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptides and general neuronal marker in psoriasis - an immunohistochemical study. Clin Exp Dermatol 1995: 20: 384-389.
36. Naukkarinen A, Jarvikallio A, Lakkakorpi J, Harvima IT, Harvima RJ, Horsmanheimo M. Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin. J Pathol 1996: 180: 200-205.
37. Szepietowski JC, Reich A, Wiśnicka B. Pruritus and psoriasis. Br J Dermatol 2004: 151: 1284.
38. Wiśnicka B, Szepietowski JC, Reich A, Orda A. Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatol Psychosom 2004: 5: 73-78.
39. Smith CH, Barker JNWN, Morris RW, MacDonald DM, Lee TH. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993: 151: 3274-3282.
40. Seike M, Ikeda M, Morimoto A, Matsumoto M, Kodama H. Increased synthesis of calcitonin gene related peptide stimulates keratinocyte proliferation in murine UVB-radiated skin. J Dermatol Sci 2002: 28: 135-143.
41. Toyoda M, Luo Y, Makino T, Matsui C, Morohashi M. Calcitonin gene-related peptide upregulates melanogenesis and enhances melanocyte dendriticity via induction of keratinocyte-derived melanotrophic factors. J Invest Dermatol Symp Proc 1999: 4: 116-125.
42. Foster CA, Mandak B, Kromer E, Rot A. Calcitonin gene-related peptide is chemotactic for human T lymphocytes. Ann New York Acad Sci 1992: 657: 397-404.
43. Fox FE, Kubin M, Cassin M et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: Effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol 1997: 108: 43-48.
44. Carucci JA, Ignatius R, Wei Y et al. Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cell and dampens dendritic cell-driven T cell-proliferative responses via the type I calcitonin gene-related peptide receptor. J Immunol 2000: 164: 3494-3499.
45. Legat FJ, Jaiani LT, Wolf P et al. The role of calcitonin gene-related peptide in cutaneous immunosuppression induced by repeated subinflammatory ultraviolet irradiation exposure. Exp Dermatol 2004: 13: 242-250.
46. Raychaudhuri SK, Raychaudhuri SP, Farber EM. Anti-chemotactic activities of peptide-T: A possible mechanism of actions for its therapeutic effects on psoriasis. Int J Immunopharmacol 1998: 20: 661-667.
47. Lazarova R, Hristakieva E, Lazarov N, Shani J. Vitiligo-related neuropeptides in nerve fibers of the skin. Arch Physiol Biochem 2000: 108: 262-267.
48. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A. Neuropeptides in skin from patients with atopic dermatitis: An immunohistochemical study. Br J Dermatol 1990: 122: 745-750.
49. Salomon J. Concentration of substance P, neuropeptide Y and calcitonine gene-related peptide in serum of patients with atopic eczema during exacerbation and remission. PhD thesis. Wrocław: Wroclaw Medical University Press, 2004.
50. Lin Q, Zou X, Ren Y, Wang J, Fang L, Willis WD. Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin. Neuroscience 2004: 123: 337-347.
51. Naveilhan P, Hassameh H, Lucas G et al. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 2001: 409: 513-517.